Novel purine derivatives are described as agents for treating autoimmune diseases as well as a method of manufacture and pharmaceutical compositions as well as novel intermediates in the manufacture thereof.
                            本发明涉及一种新型
嘌呤衍
生物,作为治疗自身免疫性疾病的药剂,以及制造方法、制药组合物和制造过程中的新型中间体。